Companies, businesses and nonprofits that are offering free supplies, resources and services to victims of the Los ...
Companies, businesses and nonprofits that are offering free supplies, resources and services to victims of the Los ...
Though Pfizer Inc.’s work on a PD-1-targeting antibody has trailed far behind that of its fellow big pharmas, the company could be the first to market in treatment-naïve, high-risk non-muscle invasive ...
Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...
Pfiz­er said its ex­per­i­men­tal an­ti-PD-1 drug best­ed the cur­rent stan­dard of care in a type of blad­der can­cer where ...
Looking for smart, simple tips to help keep you healthy? Your Health is a free, monthly e-newsletter from Johns Hopkins Medicine.